GlobeNewsWire
04 Nov 2025, 21:05 UTC · 47w ago
Verdict
Headline takes no side. We score LAB +0.40 across four claims — moderately bullish.
+0.40moderately bullish
More positive than 68% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Standard BioTools expects to achieve profitability and positive adjusted EBITDA in 2026.
So whatClear guidance on a timeline for profitability is a primary driver for valuation in growth/biotech stocks.
More positive than 94% of claims this week
The company is implementing a restructuring plan involving a 20% workforce reduction to achieve over $40 million in annualized cost savings by 2026.
So whatAggressive cost-cutting improves margins and supports the path to profitability, though it reflects current macro headwinds.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 80% of claims this week
A significant cash injection is expected from the pending sale of SomaLogic and other assets to Illumina.
More positive than 80% of claims this week
The company maintains its full-year 2025 combined revenue outlook in the range of $165 million to $175 million.
So whatReaffirming previous guidance suggests stability but lacks a new positive catalyst.
More positive than 46% of claims this week
Which stocks this story touches
More positive than 68% of ticker scores this week
The company reported solid execution, a path to profitability by 2026, and a strong balance sheet bolstered by a pending transaction.
Near neutral — 91% of ticker scores this week are stronger
Mentioned as the acquirer of SomaLogic assets, which is a neutral operational transaction.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−37.8%
Price is moving against the score
$0.7406 vs $1.19 close before publication (Nov 4) · not market-adjusted
LAB chart →